{"id":1405,"date":"2010-01-14T17:49:51","date_gmt":"2010-01-14T22:49:51","guid":{"rendered":"http:\/\/blogs.nejm.org\/cardioexchange\/thursday-january-14-roundup-plato-acc-loses-in-court\/"},"modified":"2011-07-19T17:45:06","modified_gmt":"2011-07-19T21:45:06","slug":"thursday-january-14-roundup-plato-acc-loses-in-court","status":"publish","type":"post","link":"https:\/\/blogs.nejm.org\/cardioexchange\/2010\/01\/14\/thursday-january-14-roundup-plato-acc-loses-in-court\/","title":{"rendered":"Thursday January 14 Roundup: PLATO, ACC Loses in Court"},"content":{"rendered":"<p><strong>PLATO-Invasive<\/strong>: A <a href=\"http:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736%2809%2962191-7\/fulltext\">large substudy from PLATO of ACS patients undergoing an invasive strategy has been published in the&nbsp;<\/a><em><a href=\"http:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736%2809%2962191-7\/fulltext\">Lancet<\/a>. <\/em>&nbsp;The substudy found that ticagrelor was superior to clopidogrel in&nbsp;13,408 ACS patients for whom an invasive procedure was planned. Christopher Cannon et al. reported that the combined rate of CV&nbsp;death, MI, and stroke was significantly cut from 10.7% in the clopidogrel arm to 9.0% in the ticagrelor arm. There were no additional major bleeding complications in the ticagrelor group. In&nbsp;<a href=\"http:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736%2810%2960070-0\/fulltext\">an accompanying editorial<\/a>, Gregg Stone said&nbsp;\u201cthe introduction of ticagrelor, a more potent and effective agent which is as safe as its predecessor, is a landmark event that should redefine the care of patients with acute coronary syndromes.\u201d<br \/>\n<strong>ACC loses court battle<\/strong>: A US Judge has rejected the American College of Cardiology&#8217;s lawsuit to overturn recently established cuts in Medicare reimbursement for cardiology services. The ACC said it plans to continue fighting the reduction in payments. The ACC has a <a href=\"http:\/\/www.acc.org\/advocacy\/advoc_issues\/ACCAdvocate01122010.htm\">statement on its website<\/a>.<\/p>\n<p><strong><br \/>\n<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PLATO-Invasive: A large substudy from PLATO of ACS patients undergoing an invasive strategy has been published in the&nbsp;Lancet. &nbsp;The substudy found that ticagrelor was superior to clopidogrel in&nbsp;13,408 ACS patients for whom an invasive procedure was planned. Christopher Cannon et al. reported that the combined rate of CV&nbsp;death, MI, and stroke was significantly cut from [&hellip;]<\/p>\n","protected":false},"author":196,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1405","post","type-post","status-publish","format-standard","hentry","category-general"],"_links":{"self":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts\/1405","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/users\/196"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/comments?post=1405"}],"version-history":[{"count":0,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts\/1405\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/media?parent=1405"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/categories?post=1405"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/tags?post=1405"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}